This review addresses the useof biomarkers in sepsis in pediatric patients with emphasis on C-reactiveprotein, procalcitonin, interleukins 6, 8, and 18, human neutrophil gelatinase,and proadrenomedullin. This evidence concerns the gene MMP2 and Sepsis.